Campus

Taking Shots at HPV

A new vaccine can help lower the risk of cervical cancer
In June 2006, Merck & Co., Inc. announced that the U.S. Food and Drug Administration (FDA) had approved Gardasil, the first and only vaccine developed to prevent cervical cancer, precancerous genital lesions and genital warts due to human papillomavirus (HPV).